Securing innovation through IP

We currently own three (3) proprietary patents, all filed in early 2025, and hold exclusive rights for all healthcare applications to a portfolio of patented technologies licensed from CEA Paris-Saclay and Inria. This portfolio includes five (5) CEA patents (filed between 2013 and 2023), the SERENA medical dataset, and Inria’s AI software platform JULIA, the latter two being protected through APP deposits submitted by Inria to INPI France.

The core patented technology was developed by Dr. Hakima BERDOUZ, Founder & CEO of Hope Valley AI, through over 15 years of cutting-edge R&D in risk engineering and artificial intelligence at CEA Paris-Saclay and the Inria Start-up Studio in Paris.

We are committed to building a high-value, strategically aligned intellectual property portfolio, with a sustained goal of filing more than five (5) patent applications per year to secure and protect our technological innovations across applied AI, risk engineering and digital health..